Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.74 USD | -0.37% | -2.27% | -1.92% |
13/03 | Top Premarket Decliners | MT |
12/03 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.92% | 388M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- iTeos Therapeutics : Wedbush Raises Price Target for iTeos Therapeutics Ahead of Potentially Upbeat EOS-448 Data, Maintains Outperform Rating